Study Says Best Drug Combo for Type 2 Kids Is Metformin and Rosiglitazone

| May 24, 2012

A university study has concluded that a combination of metformin and rosiglitazone (Avandia) is the best drug therapy for controlling blood sugar levels in type 2 children and adolescents. Metformin alone is the drug most often prescribed for young or recently diagnosed type 2 patients.

While the study by researchers at George Washington University and the University of Colorado shows that a combination therapy is more effective, the inclusion of rosiglitazone raises some concerns. The drug, a member of the thiazolidinedione (TZD) drug class, has been linked in Europe and the United States to an increased risk of cardiovascular problems.

The researchers began the study in 2002, before problems with TZDs were suspected. The drug was selected as a combination therapy alternative to sulfonylureas, which produce excessively high levels of hypoglycemia in young type 2s.

The TODAY (Treatment Options for Type 2 Diabetes in Adolescents and Youth) study, which involved 699 patients ages 10 to 17, examined three factors:

• The efficacy of metformin as a standalone therapy for type 2
• The efficacy of metformin and "lifestyle intervention"-changes in diet and exercise
• The efficacy of metformin and rosiglitazone as a combination therapy
The participants were split randomly into three groups. One group took metformin alone twice daily (1,000 mg), a second took the same dose of metformin plus four mg of rosiglitazone daily, and the third group took the same dose of metformin and worked on lifestyle changes that could lead to weight loss.  The goal of each mode of treatment was to achieve and maintain an A1C level of less than 8%.

The researchers reported that the rate of treatment failure, wherein patients did not achieve the 8% A1C goal, favored the combination therapy group.

• 38.6 percent of patients in the metformin and rosiglitazone combination therapy group failed to achieve the A1C goal
• 46.6 percent of patients in the metformin plus lifestyle intervention group failed to achieve the A1C goal
• 51.7 percent of patients in the group taking metformin alone failed to achieve the A1C goal

Although the combination drug therapy worked best at blood sugar control, the study found that patients taking both drugs experienced greater weight gain than those in the other two groups. The combination therapy was more effective in girls than in boys, and metformin alone worked better in whites and non-white Hispanics than it did in black youths.

While the study helps establish combination therapy as a successful approach to treating type 2 in young people, there remains the task of finding a non-TZD drug to partner with metformin that can produce similar results.

Click Here To View Or Post Comments

Categories: A1C, A1c Level, A1C Levels, Avandia/Avandamet/Avandaryl/, Blood Sugar, Blood Sugar Control, Diabetes, Diabetes, Diabetes Health, Diabetes Health Magazine, George Washington University, Metformin, Rosiglitazone, Type 2 Diabetes, Type 2 Issues, University of Colorado, Weight Loss

Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12th Annual Product Reference Guide
  • Insulin Syringe Chart
  • Insulin Pen Needles Chart
  • Fast-Acting Glucose
  • Sharps Disposal
  • Blood Glucose Meters Chart
  • Insulin Pumps Chart
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...

Username: Password:
©1991-2015 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.